Prestige Consumer Healthcare (PBH) Director Darecca James Receives 2,981 RSUs

What Happened Darecca James, a director of Prestige Consumer Healthcare (PBH), received a grant of 2,981 restricted stock units (RSUs) on August 4, 2026. The award was recorded at $0.00 acquisition price (transaction code A) and equals $155,000 based on the closing share price of $52.00 on the grant date. The RSUs vest on the first anniversary of the grant and will be settled by delivery of one share of common stock for each vested RSU upon the earliest of the director’s death, separation, or a change in control.

Key Details

• Transaction date: 2026-08-04; filing date: 2026-08-05 (Form 4) — appears timely.
• Grant: 2,981 RSUs; reported acquisition price: $0.00; implied grant value: $155,000 (2,981 × $52.00).
• Vesting/settlement: Vest on first anniversary; settled by one share per vested RSU upon death, separation, or change in control.
• Shares owned after transaction: Not specified in the provided filing details.
• Transaction code: A (award/grant).

Context RSUs are a non-cash equity award that convert into shares upon vesting; this is a compensation grant, not an open-market purchase or sale, and is common for directors. Such awards reflect standard director compensation and do not by themselves indicate a buy or sell signal.